Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.

Show other versions (1)

OBJECTIVES: Observational and genetic studies have shown that lipoprotein(a) [Lp(a)] levels and apolipoprotein(a) [apo(a)] isoform size are both associated with coronary heart disease (CHD) risk, but the relative independence of these risk factors remains unclear. Clarification of this uncertainty i...

Bibliografske podrobnosti
Main Authors:	Hopewell, J, Seedorf, U, Farrall, M, Parish, S, Kyriakou, T, Goel, A, Hamsten, A, Collins, R, Watkins, H, Clarke, R
Format:	Journal article
Jezik:	English
Izdano:	2014

Podobne knjige/članki

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease
od: Hopewell, J, et al.
Izdano: (2014)

Association of Apolipoprotein(a) Isoforms With Coronary Heart Disease is Mediated Through Plasma Lipoprotein(a) Levels
od: Hopewell, J, et al.
Izdano: (2010)

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk
od: Kyriakou, T, et al.
Izdano: (2014)

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk.
od: Kyriakou, T, et al.
Izdano: (2014)

LPA NULL MUTATION GENOTYPING AND QPCR ANALYSIS REFINE KRINGLE ISOFORM ANALYSIS OF LP(A) LEVELS
od: Kyriakou, T, et al.
Izdano: (2014)

Impact of apolipoprotein(a) isoform size on lipoprotein(a) lowering in the HPS2-THRIVE study
od: Parish, S, et al.
Izdano: (2018)

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
od: Clarke, R, et al.
Izdano: (2009)

Independent relevance of renal function for coronary artery disease
od: Hopewell, J, et al.
Izdano: (2010)

Plasma cytokines and risk of coronary heart disease in the PROCARDIS study
od: Clarke, R, et al.
Izdano: (2018)

Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study.
od: Hopewell, J, et al.
Izdano: (2011)

Common Genetic Variants Associated With Higher Lp(a) Concentrations and Increased Risk of Coronary Heart Disease
od: Clarke, R, et al.
Izdano: (2009)

ASSOCIATION STUDY OF CORONARY ARTERY DISEASE (CAD) USING HUMANCVD 50K CHIP
od: Goel, A, et al.
Izdano: (2009)

Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms.
od: Farrer, M, et al.
Izdano: (1994)

Genetic Variants in Lp(a) Lipoprotein and Coronary Disease REPLY
od: Farrall, M, et al.
Izdano: (2010)

COMMON GENETIC VARIANTS ASSOCIATED WITH LOW Lp(a) KRINGLE-IV COPY NUMBER, HIGH Lp(a) CONCENTRATION, AND INCREASED RISK OF CORONARY HEART DISEASE
od: Seedorf, U, et al.
Izdano: (2010)

Independent Relevance of Cytokines for Risk of Coronary Heart Disease
od: Clarke, R, et al.
Izdano: (2012)

Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
od: Ruotolo, G, et al.
Izdano: (1998)

Oxidized phospholipids, Lp(a) and coronary heart disease risk
od: Clarke, R, et al.
Izdano: (2012)

Apolipoprotein proteomics for residual lipid-related risk in coronary heart disease
od: Clarke, R, et al.
Izdano: (2023)

Relationship of apolipoprotein(a) isoform size with clearance and production of lipoprotein(a) in a diverse cohort
od: Anastasiya Matveyenko, et al.
Izdano: (2023-03-01)

Lipoprotein(a) Genetic Variants Associated With Risk of Atherothrombotic Disease in 14,465 Participants From the Heart Protection Study
od: Hopewell, J, et al.
Izdano: (2010)

Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.
od: Parish, S, et al.
Izdano: (2012)

Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study
od: Stefania Lamon-Fava, et al.
Izdano: (2011-06-01)

Lipoprotein (a) and apolipoprotein BD100 in coronary heart disease pathogenesis
od: K. I. Tebloev, et al.
Izdano: (2005-10-01)

Lack of genetic support for shared aetiology of Coronary Artery Disease and Late-onset Alzheimer’s disease
od: Grace, PC, et al.
Izdano: (2018)

The Impact of Genetic Variants Related to LDL-cholesterol on Risk of Ischemic Stroke and Coronary Heart Disease
od: Hopewell, J, et al.
Izdano: (2012)

USE OF ENCODE DATA TO IDENTIFY PUTATIVE FUNCTIONAL VARIANTS IN CORONARY ARTERY DISEASE GWAS
od: Goel, A, et al.
Izdano: (2014)

Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p.
od: Broadbent, H, et al.
Izdano: (2008)

Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p
od: Broadbent, H, et al.
Izdano: (2008)

Turkish Heart Study: lipids, lipoproteins, and apolipoproteins.
od: R W Mahley, et al.
Izdano: (1995-04-01)

Lipoprotein(a) Particle Production as a Determinant of Plasma Lipoprotein(a) Concentration Across Varying Apolipoprotein(a) Isoform Sizes and Background Cholesterol‐Lowering Therapy
od: Dick C. Chan, et al.
Izdano: (2019-04-01)

Relationship between Apolipoprotein E Genotype and Lipoprotein Profile in Patients with Coronary Heart Disease
od: Yahui Lin, et al.
Izdano: (2022-02-01)

Comparison of apolipoprotein B to cholesterol in low density lipoproteins of patients with coronary heart disease.
od: G L Vega, et al.
Izdano: (1984-06-01)

Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE.
od: Karpe, F, et al.
Izdano: (1994)

Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE.
od: F Karpe, et al.
Izdano: (1994-07-01)

Interactions amongst insulin, lipoproteins and haemostatic function relevant to coronary heart disease.
od: Hamsten, A, et al.
Izdano: (1994)

Clinical and Prognostic Value of Non-Fasting Lipoproteins and Apolipoproteins in Chinese Patients with Coronary Heart Disease
od: Junfeng Zhang, et al.
Izdano: (2023-11-01)

Are apolipoproteins A and B better than lipoproteins for assessing risk of obstructive coronary heart disease?
od: Waldomiro Carlos Manfroi, et al.
Izdano: (1999-06-01)

Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese
od: Kuo-Liong Chien, et al.
Izdano: (2007-11-01)

Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men.
od: Clarke, R, et al.
Izdano: (2007)